Knight; Steven David
Patent Applications and Registrations
Patent applications and USPTO patent grants for Knight; Steven David.The latest application filed is for "enhancer of zeste homolog 2 inhibitors".
Company Profile
2.38.60
- Knight; Steven David - Collegeville PA
- Knight; Steven David - West Chester PA
- Knight; Steven David - Philadelphia PA
Patent Activity
| Patent | Date |
|---|---|
| Enhancer of zeste homolog 2 inhibitors Grant 10,604,531 - Knight , et al. | 2020-03-31 |
| Enhancer of Zeste Homolog 2 inhibitors Grant 10,478,426 - Burgess , et al. Nov | 2019-11-19 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20190092785 - KNIGHT; Steven David ; et al. | 2019-03-28 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20180207144 - BURGESS; Joelle Lorraine ; et al. | 2018-07-26 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20180162845 - BRACKLEY, III; James A. ; et al. | 2018-06-14 |
| Enhancer of zeste homolog 2 inhibitors Grant 9,956,210 - Burgess , et al. May 1, 2 | 2018-05-01 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20170334891 - KNIGHT; Steven David ; et al. | 2017-11-23 |
| Enhancer of zeste homolog 2 inhibitors Grant 9,790,212 - Blackledge, Jr. , et al. October 17, 2 | 2017-10-17 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20170095461 - Burgess; Joelle Lorraine ; et al. | 2017-04-06 |
| Enhancer of zeste homolog 2 inhibitors Grant 9,562,041 - Burgess , et al. February 7, 2 | 2017-02-07 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20170029412 - BLACKLEDGE, JR.; Charles William ; et al. | 2017-02-02 |
| Enhancer of zeste homolog 2 inhibitors Grant 9,556,157 - Burgess , et al. January 31, 2 | 2017-01-31 |
| Enhancer of zeste homolog 2 inhibitors Grant 9,505,745 - Blackledge, Jr. , et al. November 29, 2 | 2016-11-29 |
| Indoles Grant 9,402,836 - Brackley, III , et al. August 2, 2 | 2016-08-02 |
| Enhancer of Zeste Homolog 2 inhibitors Grant 9,382,234 - Knight , et al. July 5, 2 | 2016-07-05 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20160130261 - BURGESS; Joelle Lorraine ; et al. | 2016-05-12 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20160122342 - FOSBENNER; David T. ; et al. | 2016-05-05 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20160102083 - BLACKLEDGE, JR.; Charles William ; et al. | 2016-04-14 |
| Indoles App 20150313887 - BRACKLEY, III; James ; et al. | 2015-11-05 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20150307480 - KNIGHT; Steven David ; et al. | 2015-10-29 |
| Azaindazoles Grant 9,073,924 - Burgess , et al. July 7, 2 | 2015-07-07 |
| Enhancer Of Zeste Homolog 2 Inhibitors App 20150126522 - Burgess; Joelle Lorraine ; et al. | 2015-05-07 |
| Azaindazoles App 20140343056 - Burgess; Joelle Lorraine ; et al. | 2014-11-20 |
| Quinoline Derivatives As Pi3 Kinase Inhibitors App 20140296224 - ADAMS; Nicholas D. ; et al. | 2014-10-02 |
| Quinoline derivatives as PI3 kinase inhibitors Grant 8,785,433 - Knight , et al. July 22, 2 | 2014-07-22 |
| Indoles Grant 8,765,792 - Knight , et al. July 1, 2 | 2014-07-01 |
| Quinoline Derivatives As Pi3 Kinase Inhibitors App 20140100234 - KNIGHT; Steven David ; et al. | 2014-04-10 |
| Quinoline derivatives as PI3 kinase inhibitors Grant 8,633,187 - Knight , et al. January 21, 2 | 2014-01-21 |
| Compounds, compositions and methods Grant 8,633,236 - McDonald , et al. January 21, 2 | 2014-01-21 |
| Indoles App 20130245016 - Knight; Steven David ; et al. | 2013-09-19 |
| Quinoline derivatives as P13 kinase inhibitors Grant 8,404,837 - Adams , et al. March 26, 2 | 2013-03-26 |
| Compounds, Compositions And Methods App 20130053436 - McDonald; Andrew ; et al. | 2013-02-28 |
| Compounds, compositions and methods Grant 8,329,928 - McDonald , et al. December 11, 2 | 2012-12-11 |
| Compounds, Compositions And Methods App 20120209012 - McDonald; Andrew ; et al. | 2012-08-16 |
| Quinoline Derivatives As Pi3 Kinase Inhibitors App 20120165321 - Adams; Nicholas D. ; et al. | 2012-06-28 |
| Quinoline derivatives as PI3 kinase inhibitors Grant 8,138,347 - Knight , et al. March 20, 2 | 2012-03-20 |
| Compounds, compositions and methods Grant 8,119,678 - McDonald , et al. February 21, 2 | 2012-02-21 |
| Compounds, Compositions And Methods App 20110230550 - McDonald; Andrew ; et al. | 2011-09-22 |
| Compounds, compositions and methods Grant 7,919,524 - McDonald , et al. April 5, 2 | 2011-04-05 |
| Pyridosulfonamide Derivatives As P13 Kinase Inhibitors App 20100311736 - Adams; Nicholas D. ; et al. | 2010-12-09 |
| Quinoxaline Derivatives As Pi3 Kinase Inhibitors App 20100234386 - Chaudhari; Amita ; et al. | 2010-09-16 |
| Thiazolones For Use As Pi3 Kinase Inhibitors App 20100216801 - Dhanak; Dashyant ; et al. | 2010-08-26 |
| Quinazoline Derivatives As P13 Kinase Inhibitors App 20100179144 - Adams; Nicholas D. ; et al. | 2010-07-15 |
| Quinoline Derivatives As P13 Kinase Inhibitors App 20100152112 - Adams; Nicholas D. ; et al. | 2010-06-17 |
| Compounds, Compositions And Methods App 20100105767 - McDonald; Andrew ; et al. | 2010-04-29 |
| Thiazolidinedione Derivatives As P13 Kinase Inhibitors App 20090306074 - Darcy; Michael Gerard ; et al. | 2009-12-10 |
| Compounds, compositions and methods Grant 7,629,477 - McDonald , et al. December 8, 2 | 2009-12-08 |
| Thiozolidinedione Derivatives As Pi3 Kinase Inhibitors App 20090215818 - Adams; Nicholas D. ; et al. | 2009-08-27 |
| Thiazolones for Use as P13 Kinase Inhibitors App 20090203732 - Dhanak; Dashyant ; et al. | 2009-08-13 |
| Methods and compositions App 20090170882 - Dhanak; Dashyant ; et al. | 2009-07-02 |
| Thiazolones For Use As Pi3 Kinase Inhibitors App 20090170848 - Dhanak; Dahsyant ; et al. | 2009-07-02 |
| Compounds, compositions, and methods Grant 7,528,137 - Feng , et al. May 5, 2 | 2009-05-05 |
| Thiazolones For Use As Pi3 Kinase Inhibitors App 20090082349 - Dhanak; Dashyant ; et al. | 2009-03-26 |
| Thiazolones For Use As Pi3 Kinase Inhibitors App 20090048252 - Dhanak; Dashyant ; et al. | 2009-02-19 |
| Compounds, compositions and methods Grant 7,491,746 - McDonald , et al. February 17, 2 | 2009-02-17 |
| Compounds, methods and compositions Grant 7,482,343 - Zhou , et al. January 27, 2 | 2009-01-27 |
| Thiazolones For Use As Pi3 Kinase Inhibitors App 20090023742 - Dhanak; Dashyant ; et al. | 2009-01-22 |
| Quinazoline Derivatives As P13 Kinase Inhibitors App 20090018131 - ADAMS; Nicholas D. ; et al. | 2009-01-15 |
| Compounds, compositions, and methods Grant 7,476,743 - Qian , et al. January 13, 2 | 2009-01-13 |
| Compounds, compositions and methods App 20090005580 - McDonald; Andrew ; et al. | 2009-01-01 |
| Quinoline Derivatives As Pi3 Kinase Inhibitors App 20080300239 - Adams; Nicholas D. ; et al. | 2008-12-04 |
| Quinoxaline Derivatives As Pi3 Kinase Inhibitors App 20080293706 - CHAUDHARI; Amita ; et al. | 2008-11-27 |
| Thiazolidinedione Derivatives As Pi3 Kinase Inhibitors App 20080255115 - Darcy; Michael Gerard ; et al. | 2008-10-16 |
| Compounds, Compositions, and Methods App 20080176830 - Adams; Nicholas D. ; et al. | 2008-07-24 |
| Modulation of KSP kinesin activity with heterocyclic-fused pyrimidinone derivatives Grant 7,332,498 - Lu , et al. February 19, 2 | 2008-02-19 |
| Novel Biphenyl Compounds And Their Use App 20070265345 - Chaudhari; Amita M. ; et al. | 2007-11-15 |
| Compounds, Compositions and Methods App 20070259951 - Parrish; Cynthia A. ; et al. | 2007-11-08 |
| Compounds, compositions and methods App 20070254870 - Bergnes; Gustave ; et al. | 2007-11-01 |
| Compounds, methods and compositions App 20070135432 - Zhou; Han-Jie ; et al. | 2007-06-14 |
| Compounds, compositions, and methods Grant 7,214,800 - Feng , et al. May 8, 2 | 2007-05-08 |
| Compounds, compositions and methods Grant 7,208,487 - Bergnes , et al. April 24, 2 | 2007-04-24 |
| Compounds, methods and compositions Grant 7,166,595 - Zhou , et al. January 23, 2 | 2007-01-23 |
| Compounds, compositions, and methods App 20060189671 - Qian; Xianping ; et al. | 2006-08-24 |
| Compounds, compositions, and methods App 20060111374 - Lu; Pu-Ping ; et al. | 2006-05-25 |
| Compounds, compositions, and methods Grant 7,041,676 - McDonald , et al. May 9, 2 | 2006-05-09 |
| Compounds, compositions, and methods App 20060094735 - Feng; Bainian ; et al. | 2006-05-04 |
| 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use Grant 7,038,048 - Lu , et al. May 2, 2 | 2006-05-02 |
| Compounds, compositions and methods App 20060052360 - Bergnes; Gustave ; et al. | 2006-03-09 |
| Compounds, compositions and methods App 20060020008 - McDonald; Andrew ; et al. | 2006-01-26 |
| Compounds, compositions, and methods App 20060019988 - McDonald; Andrew ; et al. | 2006-01-26 |
| Compounds, compositions, and methods App 20060004073 - McDonald; Andrew ; et al. | 2006-01-05 |
| Compounds, compositions, and methods Grant 6,949,538 - McDonald , et al. September 27, 2 | 2005-09-27 |
| Compounds, compositions and methods Grant 6,924,376 - McDonald , et al. August 2, 2 | 2005-08-02 |
| Compounds, compositions, and methods App 20040116438 - Lu, Pu-Ping ; et al. | 2004-06-17 |
| Compounds, compositions, and methods App 20040116400 - McDonald, Andrew ; et al. | 2004-06-17 |
| Compounds, compositions, and methods App 20040082567 - McDonald, Andrew ; et al. | 2004-04-29 |
| Compounds, compositions and methods App 20040082638 - McDonald, Andrew ; et al. | 2004-04-29 |
| Compounds, compositins, and methods App 20040077668 - Feng, Bainian ; et al. | 2004-04-22 |
| Compounds, methods and compositions App 20040077662 - Zhou, Han-Jie ; et al. | 2004-04-22 |
| Urotensin-II receptor antagonists App 20030100580 - Dhanak, Dashyant ; et al. | 2003-05-29 |
| Urotensin-II receptor antagonists Grant 6,544,992 - Dhanak , et al. April 8, 2 | 2003-04-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 